Dudediligence.

Exicure, Inc

XCURNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$1.1MSep ’24−$7.2MDec ’24$3.0MMar ’25−$2.6MJun ’25−$2.4MSep ’25−$2.9MDec ’25−$1.8MMar ’26−$1.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue−$483,000$28.8M$0.00$500,000$0.00
Operating income−$62.5M−$1.8M−$15.0M−$12.2M−$4.2M
Net income−$64.1M−$2.6M−$16.9M−$9.7M−$4.9M
Operating cash flow−$34.8M−$35.7M−$10.4M−$2.9M−$8.6M
Free cash flow−$35.8M−$35.7M−$10.4M−$2.9M−$8.6M
Cash$34.6M$8.6M$816,000$12.5M$3.7M
Debt$6.9M$0.00none on filenone on filenone on file
Shares outstanding3.6M5.0M1.8M6.0M6.4M